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ABSTRACT
Background
This paper examines the efforts of consultants affiliated with Philip Morris (PM), the world’s
leading transnational tobacco corporation, to influence scientific research and training in
Thailand via the Chulabhorn Research Institute (CRI). A leading Southeast Asian institute for
environmental health science, the CRI is headed by Professor Dr. Her Royal Highness Princess
Chulabhorn, the daughter of the King of Thailand, and it has assumed international significance
via its designation as a World Health Organization (WHO) Collaborating Centre in December
2005.
Methods and Findings
This paper analyses previously confidential tobacco industry documents that were made
publicly available following litigation in the United States. PM documents reveal that ostensibly
independent overseas scientists, now identified as industry consultants, were able to gain
access to the Thai scientific community. Most significantly, PM scientist Roger Walk has
established close connections with the CRI. Documents indicate that Walk was able to use such
links to influence the study and teaching of environmental toxicology in the institute and to
develop relations with key officials and local scientists so as to advance the interests of PM
within Thailand and across Asia. While sensitivities surrounding royal patronage of the CRI
make public criticism extremely difficult, indications of ongoing involvement by tobacco
industry consultants suggest the need for detailed scrutiny of such relationships.
Conclusions
The establishment of close links with the CRI advances industry strategies to influence
scientific research and debate around tobacco and health, particularly regarding secondhand
smoke, to link with academic institutions, and to build relationships with national elites. Such
strategies assume particular significance in the national and regional contexts presented here
amid the globalisation of the tobacco pandemic. From an international perspective, particular
concern is raised by the CRI’s recently awarded status as a WHO Collaborating Centre. Since the
network of WHO Collaborating Centres rests on the principle of ‘‘using national institutions for
international purposes,’’ the documents presented below suggest that more rigorous
safeguards are required to ensure that such use advances public health goals rather than
the objectives of transnational corporations.
The Editors’ Summary of this article follows the references.
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Release of previously conﬁdential corporate documents has
demonstrated the extensive and longstanding efforts by
tobacco companies to inﬂuence scientiﬁc understanding
and public perceptions of the health impacts of smoking
[1–3]. Tobacco companies were particularly concerned about
health risks associated with exposure to passive or second-
hand smoke, what the industry has termed ‘‘environmental
tobacco smoke’’ (ETS), and undertook broad campaigns to
confound public and ofﬁcial knowledge of those risks.
Strategies designed to ensure the release of research
ﬁndings favourable to the tobacco industry and raise doubts
regarding ﬁndings of independent science [4–9] included
funding of research at seemingly independent organisations
such as the International Life Sciences Institute [10,11];
acquisition of established research institutions, as in the case
of purchase by Philip Morris (PM) of the Institut fu ¨r
Industrielle und Biologische Forschung GmbH (INBIFO)
[12]; initiatives to undermine World Health Organization
(WHO) tobacco control programmes and agencies [13],
notably the International Agency for Research on Cancer
(IARC) [14]; and recruitment of ostensibly independent
scientists and academics.
PM’s ‘‘global strategy on environmental tobacco smoke’’
[15] stressed the particular importance of establishing
regional teams of ‘‘independent’’ experts overseen by a
‘‘coordinating scientist and American lawyers, to review
scientiﬁc literature or carry out work on ETS to the keep
the controversy alive’’ [15]. The ‘‘Whitecoat Project’’ re-
cruited scientists and academics, whose industry afﬁliations
were unpublicised, to support efforts to resist and repeal
existing smoking restrictions by reversing the ‘‘scientiﬁc and
popular misconception that ETS is harmful’’ [16].
Toxicologists were of considerable importance to the ETS
project, particularly those with expertise in the ﬁeld of
environmental toxins and their physiological, biochemical,
and epidemiological impacts. Their special value lay in their
ability to authoritatively dispute independent scientiﬁc
ﬁndings on ETS by suggesting the evidence was inconclusive
[17]. A 1987 discussion of the ETS programme in PM’s Eastern
Europe, Middle East & Africa region stressed the need to
recruit and educate ‘‘consultants(s)’’ to operate as ‘‘credible
third-party spokesmen in environmental toxicology and ETS’’
[18]. PM also hired a Washington, D. C.-based environmental
health consulting ﬁrm to identify potential consultant
scientists for Scandinavia based on their expertise in
toxicology and indoor air quality that same year [19].
The ETS Programme in Asia
Regional efforts to manipulate the conduct and dissem-
ination of scientiﬁc research in Asia have been driven by the
tobacco industry’s need to slow the spread of effective
regulation across a region that is critical both to its future
proﬁtability and to the trajectory of the tobacco pandemic.
Previous research has shown that the Asian component of this
project entailed use of consultants with specialities in
chemistry, epidemiology, occupational health, toxicology,
and building science [20], to publish articles, to lobby policy
makers, and to monitor scientiﬁc meetings [19]. Their work
placed a premium on emphasising air quality issues speciﬁc
to the region including heat, humidity, incense smoke, and
indoor cooking on coal burners [21]. These efforts provided,
according to PM, ‘‘opportunities for communicating to the
public and policy makers the relative and minor contribution
of ETS to the indoor environment within the context of the
serious indoor and outdoor air quality problems encountered
in this region’’ [22].
Scientific Initiatives in Thailand
Thailand has long been recognised as a ‘‘leader among
developing countries in getting gold-standard tobacco con-
trol policies in place’’ [23] and a key inﬂuence in the regional
development of tobacco regulation [24–27]. The country’s
comprehensive 1992 tobacco control legislation package has
been supplemented by enactment of laws requiring pictorial
health warnings on cigarette packs [28] and a ban on cigarette
displays at point of sale in retail outlets [29]. Further
measures include a series of tobacco tax increases to the
current rate of 75% [30]; and the establishment in 2001 of the
Thai Health Promotion Foundation, a state agency support-
ing public health promotion funded by a dedicated tax on
cigarettes and alcohol [31].
This level of regulation and the country’s comparatively
advanced regional research capacity are reﬂected in industry
concern to build close links with local scientists and
institutions. Previous studies describing the Asian ETS
Consultants Program, the regional manifestation of the ETS
Consultants Program, provide limited discussion of its
speciﬁc impact in Thailand [19,21]. Our analysis of tobacco
industry documents indicates that contacts with Thai
scientists, academics, and government ofﬁcials were estab-
lished by PM scientists and consultants from the late 1980s.
Of particular signiﬁcance to the Thai situation is evidence
documenting a longstanding relationship between PM scien-
tists and the Chulabhorn Research Institute (CRI) in Bangkok,
a leading Southeast Asian scientiﬁc research and teaching
institution for medicinal chemistry, environmental toxicol-
ogy, biomedicine, and biotechnology [32]. The institute has
established an impressive international proﬁle, and has
secured funding from the Thai government [33], the
Association of Southeast Asian Nations [34] and the United
Nations Development Programme [35]. Its regional signiﬁ-
cance is reﬂected in the international training courses it has
run in conjunction with WHO, including the IARC [36–38],
and with the International Union Against Cancer [39]. Its
regional capacity-building project on environmental and
industrial toxicology has included seminars in Vietnam,
Indonesia, and Malaysia [40–42], funded by the Thai govern-
ment and the United Nations Development Programme [33];
and a series of Association of Southeast Asian Nations–
funded workshops on environmental toxicology and sustain-
able development in Cambodia, Laos, and Myanmar in 2002
[43].
The CRI’s specialist environmental toxicology unit, the
International Centre for Environmental Health and Toxicol-
ogy (ICEHT), was named a Centre of Excellence in Environ-
mental and Industrial Toxicology by the United Nations
Environment Programme in 1990 [44]. More signiﬁcantly, the
ICEHT was designated a WHO Collaborating Centre for
Capacity Building and Research in Environmental Health
Science in December 2005 [44,45].
The Institute’s relationship with tobacco industry scientists
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Philip Morris Scientists and the CRIassumes particular national signiﬁcance from its president
and founder, Professor Dr. Her Royal Highness Princess
Chulabhorn Mahidol, an active scientist and the youngest
daughter of Thailand’s King Bhumibol Adulyadej [46].
This paper examines the means by which PM obtained
access to the CRI, to its scientists and students, and to the
broader Thai scientiﬁc and policy communities. It focuses in
particular on how one prominent consultant has inﬂuenced
the study of environmental toxicology at the CRI and has
developed relations with key ofﬁcials and local scientists so as
to advance the interests of PM within Thailand and across
Asia.
Methods
This study is based on analysis of tobacco industry
documents available in tobacco control community online
collections, the Legacy Tobacco Documents Library (http://
legacy.library.ucsf.edu/), which incorporates the British
American Tobacco Documents Archive, operated by the
University of California, San Francisco; and Tobacco Docu-
ments Online (http://tobaccodocuments.org/). Online docu-
ment collections operated by US-based tobacco companies
under the terms of the 1998 Master Settlement Agreement
were also searched. The provenance, mechanics, and limi-
tations of using tobacco industry documents have been
described elsewhere [47–54].
The research design reﬂects the iterative nature of tobacco
industry document research. Initial document searches
focused on possible references to the Asian ETS programme
in Thailand, and employed broad search terms as ‘‘Thailand’’,
‘‘science’’, ‘‘ETS’’, and the names of high-proﬁle individuals
involved in the ETS programme such as John Rupp [21].
Documents retrieved indicated that only one recognised Thai
scientist, Professor Malinee Wongphanich of Mahidol Uni-
versity, was recruited into the programme [19], and that
leading industry consultants Roger Perry of Imperial College,
London, and George Leslie, coordinator of the UK ETS
consultants group Association of Research on Indoor Air
[19], visited Bangkok for a series of lectures and meetings in
1993.
More signiﬁcantly, these ﬁndings yielded new terms which
generated further searches and resulted in the retrieval of
documents detailing the relationship between PM scientists
and the CRI. A total of 163 documents were retained from
searches of the collections: 98 on PM scientists and the CRI
(dated between 1994 and 2002); 33 on ETS and Thailand
(1987–2002); 19 on Walk and Thailand’s ingredients disclo-
sure regulation (1991–1998); and 13 on Asian Regional
Tobacco Industry Scientists Team (ARTIST) (1998–1999).
Documents collected were analysed using validation techni-
ques based on a hermeneutic process [55], with particular
importance attached to corroboration of interpretation
between authors and the triangulation of industry documents
with other data sources (notably via the Internet).
On a ﬁnal note related to methods used in constructing this
study, the authors emphasise that because of the extreme
sensitivity attached to discussion of Thailand’s royal family,
they decided not to consult any Thai individuals or
organisations during the development of this paper. Respon-
sibility for this study rests solely with the authors.
Results
Building Relationships: Roger Walk and Mathuros
Ruchirawat
Initial contacts with the Thai scientiﬁc community were
established by George Leslie, a key ﬁgure in the early stages of
the ETS programme [56–59], and Roger Perry of Imperial
College, London [21]. While documents indicate links
between the two consultants and the CRI [60,61], the key
individual in the development of PM’s relationship with the
Institute has been Dr. Roger Walk a toxicologist and
biochemist who has long served PM in several capacities
(see Box 1).
Walk has held leading positions at PM’s research facilities,
INBIFO [12], and the Contract Research Center [62], and has
served as Director of Worldwide Scientiﬁc Affairs. He has also
served on PM’s Scientiﬁc Research Review Committee,
created to ensure that research conducted or funded on
tobacco or smoking by PM was serving relevant corporate
needs [63], and managed its external research program that
was recently described as a vehicle to ‘‘garner scientiﬁc
credibility for PM’’ [64].
From the early 1990s, Walk’s duties entailed a signiﬁcant
focus on Asia, including roles as research fellow at PM
Scientiﬁc Affairs Hong Kong which oversaw projects in Asia,
Japan, and Australia, and acting director for the region from
1999 [65]. He was involved in two key strategies to resist the
growing social intolerance toward smoking: undermining
independent scientiﬁc discourse on ETS, and promoting, in
alliance with the hospitality industry, ‘‘accommodation’’ of
smokers and nonsmokers in bars, restaurants, and other
public settings [66].
Walk also served as secretary of ARTIST, a coalition of
overseas cigarette manufacturers operating in the region that
has actively sought to involve Asian tobacco monopolies and
companies [67]. In this role, he oversaw implementation of
strategies to support science on new technologies for
improvements to indoor air quality, and promote accom-
modation strategies premised on ‘‘an environment where
smokers and nonsmokers can comfortably coexist’’ [68,69].
In 1996, Walk was charged with planning the tobacco
Box 1
Roger Walk’s Positions at PM and Affiliated Institutions
  Manager, Philip Morris External Research Program 2000 onwards;
  Director, PM Scientific Affairs 2003 onwards;
  Director, PM Worldwide Scientific Affairs 1999 onwards;
  First secretary of Asian Regional Tobacco Industry Scientists Team
(ARTIST) 1999;
  Acting Director Asia/Japan/Australia 1999 onwards;
  Research Fellow, PM Worldwide Scientific Affairs 1999;
  Research Fellow, PM Scientific Affairs, Asia-Japan-Australia,
(Hong Kong) 1996–1999;
  Executive Scientist, Asia, Institut fu ¨r Industrielle und Biologische
Forschung GmbH (INBIFO) 1995–1996;
  General Manager, Contract Research Center (CRC) 1988–1995;
  Research Director, INBIFO 1985–1988;
  Scientist, and Department Head, INBIFO 1978–1985.
Source: Glossary of Names for Philip Morris USA, Inc. Privilege Log [65].
Note: Walk is also referred to as Ruediger Walk in some documents, and
listed as Walk, Ruediger A., Dr. (Roger) in the PM Glossary of Names
included in its Privileged Log.
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Philip Morris Scientists and the CRIindustry’s response in Asia to the pending IARC report on
ETS [67], and developed PM’s ‘‘Plan for Asia 1996/1997.’’ The
report identiﬁed opportunities to maintain the social accept-
ability of smoking in the region, to ensure favourable
regulation, and to ‘‘communicate our views to, and put the
issues into perspective with, opinion leaders and the public,
and position PM as a reasonable partner in the decision-
making process’’ [22].
Walk’s Activities in Thailand
Information obtained via searches of the document
collections indicates that Walk’s principal contact at the
CRI has been Dr. Mathuros Ruchirawat, the current Vice
President for Research [70], Deputy Director of the WHO
Collaborating Centre, and an associate professor in the
department of Pharmacology at Mahidol University in
Bangkok [71]. PM documents indicate both that Mathuros
has long recognised Walk’s connections to the tobacco
industry, and has regarded them as unproblematic. In 1993,
Walk stated that ‘‘CRC’s and INBIFO’s afﬁliation with PM is
known to the main coordinator (Dr Mathuros) but probably
not to the other scientists’’ [72]. At a 1999 meeting between
PM scientists and CRI ofﬁcials in Bangkok, Mathuros
reportedly reafﬁrmed her readiness to work with the tobacco
industry [73].
Walk appears to have initially contacted Mathuros in
October 1991 to request a meeting during a forthcoming trip
to Bangkok [74]. Correspondence in early 1992 reveals that
topics raised at the meeting included an upcoming CRI
science congress and the institute’s planned construction of
an inhalation research laboratory [75]. Having informed
Mathuros that he would attend the Second Princess Chulab-
horn Science Congress in December 1992, Walk proposed
making a ‘‘contribution to the scientiﬁc program’’ [75].
Following consultation with Richard Carchman [76,77], then
PM’s manager of biochemical research and later director of
scientiﬁc affairs [65], he submitted an abstract for a poster
based on INBIFO data previously presented at a May 1990
meeting of the Gesellschaft fu ¨r Umwelt-Mutationsforschung
[77], the German-speaking section of the European Environ-
mental Mutagen Society.
Walk also invited the Princess, Mathuros, or ‘‘any other
distinguished Thai toxicologist’’ [75] to inspect inhalation
facilities at the CRC in Belgium and those of its ‘‘sister
institute’’ the INBIFO in Cologne, adding that he hoped to
‘‘be of assistance to the further development of toxicology in
your country’’ [75]. Documents indicate that Mathuros visited
PM-run facilities in Europe on at least three occasions
between August 1992 and July 1994 [78–82], and during the
1992 trip she and Walk discussed his support for the CRI’s
efforts to secure ‘‘training positions for young Thai toxicol-
ogists in Germany’’ [83].
Walk was also offered his ﬁrst direct association with the
institute in the form of consultancy work on an inhalation
laboratory project [78]. His extensive correspondence with
Mathuros details discussions of the project’s technical
speciﬁcations [84–88], and of consultancy trips to Bangkok
[89–91]. Much of the cost of Walks’ trips to Bangkok were
underwritten by the CRI via funding from the Deutsche
Gesellschaft fu ¨r Technische Zusammenarbeit, a German
development fund [92–95].
Lawyers, Science, and Regulation in Southeast Asia
The critical role of lawyers in tobacco industry efforts to
manipulate scientiﬁc and regulatory affairs is well established
via both academic research [96–99] and litigation [100].
Walk’s key contact with PM’s legal division during the early
1990s appears to have been Tony Andrade of the legal ﬁrm
Shook, Hardy & Bacon, a US-based law ﬁrm that has acted as
counsel for the tobacco industry internationally [65,100–103].
Andrade was seconded to PM’s in-house legal department in
Lausanne, Switzerland from 1991 until 1995, serving as Vice
President, PM Worldwide Regulatory Affairs [65].
Correspondence between Walk and Andrade frequently
touched on developments at the CRI, which Walk described
as ‘‘the leading institution in bioresearch and toxicology in
Thailand (and probably Southeast Asia)’’ [72]. In July 1992,
Walk informed Andrade of his planned participation in the
Second Princess Chulabhorn Science Congress in November,
suggesting it would ‘‘expand our relations to Thai scientists’’
[83]. His post-conference report depicted the congress as ‘‘an
excellent forum to develop new relationships with Thai
scientists, which could be useful in the future’’ [104], adding
that he had ‘‘focussed on local Thai scientists (e.g. institute
heads at the Kasetsart University, Bangkok) being involved in
research and administration of food ingredients’’ [104].
A further source of Walk’s claimed success in insinuating
himself within the Thai scientiﬁc community was his
consultancy work for the CRI: ‘‘[i]n this context, I am
interacting not only with the key-staff of the Chulabhorn
Research Institute including the Princess but also with high-
ranked ministry ofﬁcials being involved in the building
project. I think that this support will open many doors for
us’’ [104].
In June 1993, Walk informed Andrade of his further
progress in developing ‘‘scientiﬁc contacts with CRI and
other Thai scientists’’ over the preceding year and a half [72].
Among those Walk described as contacts were top level
ofﬁcials at the CRI including the Princess, Mathuros, Professor
Wichit Srisa-an, the institute’s Vice President, and Professor
Stitaya Sirisinha, who headed the Institute’s Laboratory of
Immunology. Others named by Walk included two CRI
scientists who were also faculty at Mahidol University, a
department head from Kasetsart University, and an ofﬁcial
from the Ministry of Public Health [72]. Walk also noted that
he been ‘‘added to the external advisory board of the CRI and
invited to give a course on inhalation’’ [72], and that his
growing responsibilities were ‘‘well suited to sustain a good
personal scientiﬁc relationship to Thai scientists and to be
asked for advice in inhalation toxicity related issues’’ [72].
Such networking occurred in the context of attempts by
transnational tobacco corporations to undermine Thailand’s
comprehensive 1992 Tobacco Products Control Act [105],
which included a requirement for public disclosure of
cigarette ingredients. A previous study demonstrates PM’s
key role in the campaign to undermine disclosure regulation
[106], and Andrade served on PM’s three-man ‘‘ingredients
task force’’ that sought to coordinate a consistent response to
ingredients disclosure issues internationally and across the
industry [107].
PM documents indicate that Walk was also closely involved
in discussions with leading PM strategists on ingredients
disclosure tactics [108–114]. The two year plan for PM
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division to supporting corporate activities to oppose by-
brand disclosure of ingredients in Thailand by ‘‘assisting in
the timely provision of ingredient information in an
appropriate context where required’’ [22], and a January
1992 memorandum from Andrade (‘‘Philip Morris Counsel’’)
to Walk (‘‘Philip Morris Employee’’) concerned contacts with
local Thai scientists regarding the ingredients disclosure
legislation [115], though its contents are not publicly
accessible [116].
Walk’s Contribution to Curriculum Development
In 1993 Walk was offered a teaching post on an upcoming
inhalation course that was ‘‘part of the institute’s interna-
tional training courses in toxicology’’ [72]. He was subse-
quently offered a renewable two year contract by Mathuros in
October 1993 to act as an ‘‘expert consultant in establishing
biomedical research facilities and an inhalation toxicology
program’’ [117]. Later that year, Walk sought to further
expand his role within the CRI, reminding Mathuros that he
was willing to contribute to ‘‘scientiﬁc activities of the CRI
especially in the area of environmental toxicology and
carcinogenesis’’ [118].
This growing involvement in curriculum development was
detailed in a July 1994 letter to PM’s Manager of Worldwide
Regulatory Affairs Jan Goodheart in New York. Walk
reported that he had been added to the international faculty
on a UN-funded [82] post-graduate environmental toxicol-
ogy, technology, and management programme that the CRI
planned to launch in 1996 in collaboration with the Asian
Institute of Technology [119,120].
He also advised Goodheart that he had been asked to
organise a symposium or workshop ‘‘on a current topic of
toxicology’’ for the CRI’s international conference on
environmental toxicology in 1996 [82]. The resulting one-
day pre-conference workshop on 9 December 1996 focused
on indoor air quality and health, and consisted of presenta-
tions by Walk, industry consultant Ragnar Rylander [12,121],
and Max Eisenberg [122], director of the industry-led Center
for Indoor Air Research [5,123]. Tobacco industry links of the
three presenters were not listed in the day’s program, nor
were they in a previous CRI call for abstracts [124].
Walk’s expertise was also sought by the CRI in developing
other programme course units, ‘‘e.g. Environmental Risk
Assessment and Management or Study Design or a seminar
on speciﬁc ‘cases’ in toxicology’’ [82]. In 1999, he was ‘‘invited
to further contribute to the joint Environmental Toxicology
program of the Asian Institute of Technology, CRI, and
Mahidol University, Bangkok’’ noting that ‘‘[t]hree years ago I
contributed together with a group of international experts to
the development of the curriculum of this program’’ [125].
His participation, he suggested, would ‘‘support our core
strategy of developing venues for the objective presentation
of high quality scientiﬁc data’’ [125]. In accepting this latest
appointment, Walk wrote to Mathuros suggesting that his
greatest potential contributions to the program would be, ‘‘in
principle, all areas of environmental and occupational
toxicology’’ [126].
The 1999 Symposium
A January 1999 meeting between PM scientists Walk,
Mingda Zhang, and Raymond Lau, and CRI faculty Mathuros,
Dr. Jutamaad Satayavivad, and Dr. Amniporn illustrates the
scope of engagement with toxicology research that the CRI
provided the tobacco corporation. In expressing ‘‘the
institution’s appreciation’’ [73] for Walk’s consultancy work
and his contribution to the postgraduate curriculum,
Mathuros added that the institute ‘‘would welcome oppor-
tunities to corporate [sic] with the Industry on scientiﬁc
issues. Such corporations [sic] will be evaluated on its
scientiﬁc merits and should not be affected by the political
issues associated with the industry in some environments’’
[73].
Speciﬁcally, she asked PM to ‘‘corporate [sic] and support
research in the area of indoor air exposure assessment in
Thailand,’’ and encouraged Walk ‘‘or other scientists from
PM to become visiting professors of the Institute and give
lectures to students in the postgraduate program in toxicol-
ogy’’ [73]. Mathuros also requested ‘‘Walk’s assistance and
PM’s support in organizing a half-day workshop on indoor air
quality’’ [73], as part of the Fourth Princess Chulabhorn
Science Congress. This last request was apparently based on
the success of the 1996 pre-conference scientiﬁc workshop
described above [73].
The result was Symposium 10 of this Congress, ‘‘Indoor Air
Quality,’’ on 1 December 1999. Chaired by Walk and Dr.
Elizabeth Anderson of Sciences International USA, and
formerly of the US Environmental Protection Agency [127–
130], the line-up of speakers included Walk, PM’s Raymond
Lau, Dr. Keith Phillips of Covance Laboratories UK, and
Anderson. Philips had previously undertaken research pro-
jects commissioned by the tobacco industry [131], while
Anderson had acted as a consultant to tobacco companies
challenging US EPA proposals on pesticide regulation
[132,133]. PM funded Walk and Lau’s travel expenses, and
contributed US$12,000 toward the expenses of other speakers
including Anderson and Phillips [134]. Mathuros wrote on
behalf of the CRI and the Congress organising committee to
‘‘thank Philip Morris USA for this generous support’’ [127].
As described by Walk, overseeing the symposium presented
PM with an opportunity to ‘‘develop a venue for the objective
publication and presentation of high-quality scientiﬁc results
(credibility core strategy)’’ and to ‘‘provide quality informa-
tion on technical solutions in support of accommodation’’
[125].
Such opportunities represented ‘‘core strategies of WSA
[PM Worldwide Scientiﬁc Affairs] and are fully integrated
into our business goals’’ [125]. Proceedings for the congress
were published in 1999 [135] but are not available via
accessible tobacco industry document collections or other
online sources.
Benefits of the CRI Connection to PM
The value of Walk’s relationship with the CRI has been his
ability to establish contacts at the institute, within the wider
Thai scientiﬁc community and, particularly, to inﬂuence
curriculum design on toxicology. Importantly, the signiﬁ-
cance of this association extended beyond Thailand: ‘‘[i]n
summary: The CRI takes a leading position in the training
and development of local manpower in toxicology in the
Paciﬁc. Their focus during the next 5 years is in training of
experts who can serve as regulators at government agencies
and their scientiﬁc advisors...To contribute to these training
efforts will signiﬁcantly help to ensure scientiﬁc objectivity
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Philip Morris Scientists and the CRIand enforce the views that local problems in these countries
cannot always be solved by adopting ‘solutions’ from the US
or Europe’’ [82].
Further evidence of the value of the CRI connection to PM
is provided by a short 1999 report, ‘‘How have interactions
with regulators and scientists furthered our objectives?’’ in
which Walk highlighted four key contributions under the
heading Credibility and Accommodation of Smokers and
Nonsmokers Core Strategies: ‘‘Invitation to organize Indoor
Air Quality Seminar at Princess Chulabhorn Congress,
Bangkok: Example for development of venues for publica-
tion’’; ‘‘Continuous support of Executive VP for Scientiﬁc
Research [Mathuros] with public quality science information,
presenting research data at previous scientiﬁc conferences,
execution of contract projects with scientiﬁc excellence’’;
‘‘Invitation to contribute as lecturer to toxicology postgrad-
uate training program in Thailand: Example for development
of venues for publication and presentation’’; ‘‘Contribution
to development of training curriculum as expert in inhala-
tion toxicology’’ [136].
Postscript: The International Centre for Environmental
Health and Toxicology
The Web site of the ICEHT, the CRI’s specialist toxicology
unit, demonstrates that tobacco industry consultants contin-
ue to exert inﬂuence on the work of the institute. Walk is
currently (at the time of this writing) cited amongst visiting
faculty on the ICEHT Inter-University Post-Graduate Educa-
tion Program on Environmental Toxicology, Technology and
Management, and is described as Roger Walk, Ph.D. (Biology)
from Ruhr-University Bochum, Germany [137]. His afﬁliation
on the announcement for an August 2006 post-graduate
course in Environmental Toxicology, Technology and Man-
agement, however, is given as ‘‘Director, Worldwide Scientiﬁc
Affairs PM, USA AND Acting Director Asia-Japan-Australia
(Richmond VA) USA’’ [138]. He is also listed as visiting faculty
on Mahidol University’s Environmental Science, Technology
and Management Web site, where his afﬁliation is given as
Worldwide Scientiﬁc Affairs PM, USA [139].
The Web site also reveals the roles of Donald J. Ecobichon
and J. F. Borzelleca, both of whom have long-standing ties to
the tobacco industry [140,141], in teaching at the ICEHT.
Ecobichon, who helped organise the tobacco industry-
sponsored 1989 McGill ETS symposium [142–144], was
amongst the faculty on the CRI’s training course on environ-
mental and industrial toxicology in 1991 [145] and 1994 [146];
on the joint CRI-Asian Institute of Technology course in 1995
[147]; and on a series of workshops on environmental
toxicology and sustainable development held in Cambodia,
Laos, and Myanmar in 2002 [43]. He is currently (at the time
of this writing) listed as visiting faculty on the ICEHT Web
site [137], as an expert advisor on the institute’s internet-
based information exchange service [148], and has contrib-
uted to Introduction to Environmental Toxicology [149], a set of
training modules used at the institute. Borzelleca, emeritus
professor at Virginia Commonwealth University, has worked
as an outside consultant with the American Tobacco
Company and PM since 1980 [141] and edits the journal Food
and Chemical Toxicology, which has published studies by a
number of tobacco company scientists [150]. His association
with the CRI is similar to Ecobichon’s, having taught on a
number of training courses [145,146,151] and contributed to
Introduction to Environmental Toxicology [149].
The 2005 designation of ICEHT as a WHO Collaborating
Centre for Capacity Building and Research in Environmental
Health Science is the most signiﬁcant example from a broad
range of connections between CRI and WHO. The institute is
an approved institution for WHO staff fellowship placements
[152], and its toxicology research facility is listed as a
Sustainable Development and Healthy Environments Collab-
orating Centre by the WHO South-East Asian Regional Ofﬁce
(SEARO) [153]. In 2002, the CRI hosted WHO’s International
Conference on Environmental Threats to the Health of
Children [154], and in 2003 organised a workshop on
children’s health and the environment in cooperation with
the WHO and its SEARO and Western Paciﬁc Regional Ofﬁce
regional agencies [155].
There has also been extensive collaboration on environ-
mental issues. The institute collaborated with WHO’s
Sustainable Development and Healthy Environments Cluster
in organising a December 2004 meeting in Geneva; a key
outcome was an agreement between Princess Chulabhorn, the
WHO, and the WHO Kobe Centre to cooperate on priority
research into environmental health issues [156]. In 2005 and
2007, the institute co-hosted ministerial regional forums on
environment and health in collaboration with WHO, the
Asian Development Bank, and the United Nations Environ-
ment Programme [157,158].
In the ﬁeld of chemical safety, the Princess is a recent
recipient of WHO’s Intergovernmental Forum on Chemical
Safety agency’s special recognition award [159]. CRI Vice
President for Research Mathuros is a member of the advisory
group of WHO’s task group on environmental health risks to
children [160], and has represented SEARO at recent steering
committee meetings of WHO’s International Programme on
Chemical Safety [161,162].
Discussion
The documents analysed above demonstrate how tobacco
industry scientists have established durable relationships with
the CRI, a key regional centre of scientiﬁc training and
expertise in Thailand. The royal connection makes any
critical discussion of the institute within Thailand an
extremely delicate matter. The King commands enormous
public respect and affection, and is regarded as a semi-divine
ﬁgure [163,164]. Public criticism of the monarchy remains
off-limits, not least because the Thai state has aggressively
used le `se-majeste ´ - the proscription of any perceived insults
to the monarchy - to protect the crown [165–167]. This
prohibition has resulted in a near total absence of any critical
analysis of the royal family.
The establishment of close links with the CRI not only
advances industry strategies to inﬂuence scientiﬁc research
and debate around tobacco and health, particularly regarding
ETS, but allows it to form links to academic institutions [168–
170] and to build relationships with national elites [171–173].
Such strategies are familiar in North and South America and
in Europe, but assume particular signiﬁcance in the national
and regional contexts presented here.
The importance attached by tobacco companies to devel-
oping links with research institutions and individual scientists
cannot be understood in isolation from broader policy
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assumed heightened signiﬁcance in the context of Thailand’s
comprehensive 1992 Tobacco Products Control Act, which
included a requirement for public disclosure of cigarette
ingredients [105]. Transnational tobacco corporations oper-
ating in Thailand mounted an aggressive challenge to the
disclosure clause [106], diluting it to the extent that a leading
advocate of the Act has described the ﬁnal version of the
ingredients regulation as ‘‘useless’’ [174].
More broadly, the documents reviewed above indicate that
this association with the CRI served to promote PM’s regional
interests via interactions with faculty, government ofﬁcials,
and local scientists and provided important opportunities to
advance industry arguments in symposia and publications.
The organisation of sponsored symposia on ETS at CRI as
elsewhere in Southeast Asia [20] has been particularly
important to tobacco corporations. It has been previously
demonstrated that proceedings of such symposia can have an
important policy impact ‘‘because they are often cited as if
they are peer-reviewed articles, as if they are balanced reviews
of the scientiﬁc literature, and with no disclosure of their
industry sponsorship’’ [175]. Furthermore, the active and
ongoing involvement of industry consultants in curriculum
development and the training of future researchers and
regulators is particularly disturbing and, in our view, wholly
inappropriate.
Thailand’s political system places a particular premium on
securing close relationships with key individuals, and indeed
the successes of the country’s remarkable tobacco control
movement owe much to the personal connections of key
health advocates [176]. It is clearly difﬁcult to assess the
validity or consequences of Walk’s claim to have developed
links with ‘‘high-ranked ministry ofﬁcials’’ [104] but the
achievement of a clear, albeit indirect, link with Thailand’s
powerful and revered royal family is of real national
signiﬁcance.
The family’s historic interest in health issues is evident in
King Bhumibol’s 1992 establishment of the Prince Mahidol
Award, conferred annually upon individuals or institutions
which have demonstrated outstanding international contri-
butions to advancing medical and public health services [177].
Previous awardees include leading tobacco control research-
ers Sir Richard Doll, Sir Richard Peto, and Jonathan Samet, as
well as Margaret Chan, the current Director General of WHO.
The association of a research institute that enjoys royal
patronage with the world’s largest cigarette corporation
contrasts starkly with Prince Mahidol’s status as the ‘‘father
of modern medicine and public health of Thailand’’ [177].
From an international perspective, particular concern is
raised by the CRI’s recently awarded status as WHO
Collaborating Centre for Capacity Building and Research in
Environmental Health Science with the responsibility to
‘‘promote & assist capacity building activities in Environ-
mental Health Toxicology & Risk Assessment’’ [178]. The
persistent involvement of industry consultants in CRI
activities described above is hard to reconcile with the
recommendations of the Zeltner committee inquiry into
tobacco industry inﬂuence within WHO in 2000 [13]. These
recommendations sought, inter alia, clariﬁcation, strengthen-
ing and expansion of rules against conﬂict of interest
involving the tobacco industry; additional safeguards against
industry efforts to distort scientiﬁc research associated with
WHO and afﬁliated organizations; and countering of industry
tactics to oppose tobacco control in developing countries
[179].
The committee also clariﬁed that its recommendations to
protect the integrity of WHO’s decision making were
‘‘intended for application throughout WHO, including within
its Collaborating Centers’’ [13]. It is not clear whether the
relationships described above directly contravene the rec-
ommendations or revised WHO practices, but their persis-
tence suggests the need to strengthen WHO’s response to the
committee’s recommended ‘‘steps to educate their scientiﬁc
investigators and collaborators about tobacco company
efforts to undermine research’’ [180].
The director of WHO’s Tobacco Free Initiative was
recently reported as stating that the organisation had placed
‘‘a complete ﬁrewall’’ between itself and tobacco companies
[181]. The links between PM scientists and a WHO Collab-
orating Centre outlined here suggest that this ﬁrewall is not
impenetrable, and highlight a much broader challenge posed
to international tobacco control efforts, notably with respect
to Article 5.3 of the WHO Framework Convention on
Tobacco Control, which addresses the need to protect public
health policies from the vested interests of the tobacco
industry [182].
Questions around inadequate oversight of conﬂicts of
interest are echoed in wider concerns about WHO relations
with the private sector [183–186] while WHO monitoring of
Collaborating Centres was subject to severe criticism in the
context of inﬂuenza vaccine development [187]. Since the
network of WHO Collaborating Centres rests on the
principle of ‘‘using national institutions for international
purposes’’ [188], the documents presented above suggest that
more rigorous safeguards are required to ensure that such
use advances public health goals rather than the objectives of
transnational corporations.
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Background. Tobacco use kills 5.4 million people a year (one person
every six seconds) and accounts for one in ten adult deaths worldwide.
Globally, the use of tobacco is on the rise, especially in developing
countries, which have become a major target for tobacco industry
marketing. The tobacco industry has worked hard to try and influence
public perceptions about the risks of smoking and the risk of inhaling
secondhand smoke (passive smoking). The industry has used a variety of
tactics to downplay the health hazards of smoking or inhaling
secondhand smoke—two examples are publishing articles casting
doubts about the health hazards of tobacco and funding research that
is biased toward giving pro-industry results. Another tactic is for tobacco
industry consultants to try and gain entry to universities and other
academic centers to see if they can influence research and teaching
activities.
Why Was This Study Done? The researchers were concerned that
consultants from the tobacco company Philip Morris had gained access
to an academic research center in Thailand called the Chulabhorn
Research Institute (CRI). The CRI is an internationally renowned teaching
institution for a variety of scientific disciplines, including environmental
toxicology (the study of how chemicals in the environment, such as
tobacco smoke, can affect human health), biomedicine, and biotechnol-
ogy. The institute has secured funding from the Thai government, the
Association of Southeast Nations and the United Nations Development
Programme. In 2005 the institute’s environmental toxicology unit was
designated a World Health Organization (WHO) Collaborating Centre.
WHO Collaborating Centres are ‘‘institutions such as research institutes,
parts of universities or academies, that are designated by the Director-
General of the WHO to carry out activities in support of the WHO’s
programs’’ (http://www.who.int/collaboratingcentres/en/). The research-
ers were concerned that Philip Morris consultants had been able to
develop relationships with the CRI to help advance the company’s
interests.
What Did the Researchers Do and Find? The researchers analyzed
previously confidential tobacco industry documents that were made
publicly available online following litigation in the United States. They
searched two online collections of industry documents—the Legacy
Tobacco Documents Library and Tobacco Documents Online—as well as
the online collections operated by US-based tobacco companies. They
found that consultants to Philip Morris were able to gain access to the
scientific community in Thailand. A Philip Morris scientist named Roger
Walk was able to establish close connections to the CRI, and he used
these connections to influence research and teaching activities at the CRI
on environmental toxicology. Walk was also able to build relationships
with government officials and scientists in Thailand to help advance the
interests of Philip Morris in the country and across Asia.
What Do these Findings Mean? This study provides evidence that the
tobacco industry has established close links with a research institute in
Thailand that collaborates with the WHO, and has been able to influence
the institute’s teaching curriculum and research. Such links are of great
concern to the public health community, which is working hard to
reduce deaths and disease due to tobacco. These links raise the
possibility that the tobacco industry is managing to influence medical
research and teaching at academic institutions. The WHO has stated that
a firewall is in place between itself and the tobacco industry—but the
study authors argue, based on their findings, that ‘‘this firewall is not
impenetrable.’’ The study findings, they conclude, highlight a challenge
posed to international tobacco control efforts, especially with respect to
Article 5.3 of an international treaty called the WHO Framework
Convention on Tobacco Control; Article 5.3 addresses the need to
protect public health policies from the vested interests of the tobacco
industry. The authors say that better safeguards must be put in place to
prevent tobacco companies from thwarting public health goals.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050238.
  The Legacy Tobacco Documents Library contains over 9.7 million
documents created by tobacco companies
  Tobacco Documents Online contains over 4 million tobacco industry
documents
  Over 900 WHO Collaborating Centres are at work in 99 Member States
on many health disciplines
  The WHO held an inquiry in 2000 into possible tobacco industry
influence over the organization (and over other UN agencies), and has
published its recommendations in response to this inquiry
  The WHO Framework Convention on Tobacco Control is an interna-
tional treaty on controlling tobacco
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